Skip to main content
OpenTrials
Completed

NCT Number: NCT03222258

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

This study evaluates the change of quality of life, treatment decision and utilization of health care depending on the use of palliative care in advanced cancer patients by a prospective cohort study. Participants will be separated into different groups by their intentions for using palliative care. Every participant will carry out the questionnaire per 3 months. This cohort study will be ended a year after each participant enrolls. However, if the participant didn't survive during this study, the caregivers will be asked to fill out additional questionnaire after 3 months of the death.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients with advanced cancer report physical, emotional, social and economic problems that may be due to the cancer itself or its treatment. Previous studies have shown the benefit of early palliative care in oncology. However, many Korean patients tend to start palliative care late even in general hospital. Because of the late start of palliative care, the burden of medical expenses increases, on the other hand, the quality of life of terminally ill patients decrease.

In this study, the use of palliative care in advanced cancer patients will be evaluated by a prospective cohort study. The goals of this study are as follow:

First, the clinical, psycho-social, and cognitive factors affecting quality of life, decision making, and hospital utilization (palliative medical team medical treatment, hospice and medical care) of patients with advanced stage cancer will be investigated.

Second, this study will explore the effects of age-specific characteristics on quality of life and care.

Third, an index, which reflects age-specific characteristics and predicts the time and content of terminal care will be developed. Improvements on the quality of life and care of patients with advanced stage of cancer or metastatic cancer are expected to establish effective terminal care strategies through this study.

The patients' symptom and quality of life, choice of medical care, advance care planning and caregiver's burden of care will be evaluated every 3 months after confirming the willingness to use palliative care for cancer patients. 3 months after the death, a caregiver evaluation will be conducted and hospice use, medical expenses will be analyzed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

[Adult Patients]

Inclusion criteria

  • 19 years of age or older and diagnosed as cancer older than 19 years of age
  • Stage 4 of advanced Breast Cancer, Colon cancer, gastric cancer, pancreatobiliary cancer, lung cancer, Liver Cancer or Malignant hematologic neoplasm
  • Patients under one of the following status : 1) under the standard chemotherapy, 2) interrupted state of standard chemotherapy, 3) under the additional chemotherapy after standard chemotherapy, 4) terminating state of any chemotherapy yet expected to be survive more than 6 months.
  • who understand the purpose and method of the study and sign with informed consent form.

Exclusion criteria

  • who are unable to participate due to poor cognitive capacity
  • who cannot read or understand Korean language
  • who are unable to complete surveys due to physical conditions

[Pediatric Patients]

Inclusion criteria

  • Who was diagnosed as pediatric cancer between 0-18 years of age.
  • Younger than 30 years of age
  • Patients under one of the following status : 1)recurrence after 2nd standard chemotherapy or without remission in leukemia, 2) recurrence after stem cell transplantation, 3) diagnosed as the cancer of poor prognosis : ATRT, glioblastoma multiforme, brainstem glioma etc.
  • Patients or their proxy understand the purpose and method of the study and sign with informed consent form.

Exclusion criteria

  • Parents of patient are unable to participate due to poor cognitive capacity
  • Parents of patient do not have legal responsibility or rights of the patient
  • Parents of patients cannot speak, read or understand Korean language

Treatment and study plan

Early palliative care

Behavioral

Palliative Care Team provide a self-learning booklet, medical treatment and consultation about Advance Care Planning with chemotherapy by oncologist.

Routine hospice care

Behavioral

Palliative Care Team provide a routine hospice care the same as other patients who doesn't participate this study after the chemotherapy is totally terminated

Primary outcomes

  1. Change from baseline Overall QOL of EORTC QLQ - Core 15 at 6 months items

    Time frame: Baseline, 3 months, 6 months

    to measure quality of life of adult patients developed by European Organisation for Research and Treatment of Cancer for Palliative Care

Secondary outcomes

  1. Patients survival and Physicians Orders for Life Sustaining Treatment (POLST) documentation

    Time frame: Baseline, 3 months, 6 months

    Patients survival and POLST(Physician Order for Life-Sustaining Treatment) documentation whether patients survive during the study period and write POLST documentation (Since POLST has no legal form in Korea, it is based on the format of each institution.)

  2. Patient Health Questionnaire-9

    Time frame: Baseline, 3 months, 6 months

    "Patient Health Questionnaire-9 items" is used as assessment tool to measure depression of both patients and their caregivers by completing the questionnaire.

  3. Decision Conflict Scale

    Time frame: Baseline, 6 months

    "Decision Conflict Scale" is used as assessment tool to measure a level of decision conflict in treatment of both patients and their caregivers by completing the questionnaire.

  4. Understanding the illness

    Time frame: Baseline, 3 months, 6 months

    to measure the awareness of patients' status of prognosis in both patients and caregivers through two questions in the questionnaire. The first question is about the idea of the possibility of curing the patient's disease and asks patients thought about whether treatment is available for cure and prolong survival. The second question concerns the life expectancy of the patient.

  5. Self-reported Health Status

    Time frame: Baseline, 3 months, 6 months

    to measure the perceived holistic health status(physical, mental, social, spiritual and general) in both patients and caregivers. caregivers (The patient is asked to answer the perceived health status into five stages.)

  6. KG-7(The Korean Cancer Study Group Geriatric Score)

    Time frame: Baseline, 3 months, 6 months

    To measure Daily functional skills in elderly only in 65-year or order patients.

  7. Medical cost in KRW/person/month

    Time frame: 3 months, 6 months

    Direct medical cost will be collected through National Health Insurance Corporation and Indirect cost will be collected by caregiver's questionnaire. In addition, "EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L)" tool will be included in the patient's questionnaire to measure the condition of patients at the same time.

  8. Utilization of healthcare services

    Time frame: 3 months, 6 months

    In order to analyze the cost effectiveness, investigate the frequency of use of early palliative care programs, the use of life-sustaining treatment and hospicee, and the use of complementary and alternative medicine(CAM). CAM include Chinese medicine, aromatherapy, diet, and yoga, etc.

  9. Preference of Advance care and Palliative care

    Time frame: 3 months, 6 months

    to assess the patient's awareness of advanced care planning and willingness to construct advanced care planning. The preference for palliative care is divided according to the life expectancy. Investigate the preference of palliative care in each case - if the life expectancy is within a year, within a few months, or within a few weeks.

  10. Mcgill Quality of Life (MQOL)

    Time frame: Baseline, 3 months, 6 months

    To measure mental, social, spiritual quality of life of both patients and caregivers

  11. Pediatric Quality of Life Inventory

    Time frame: Baseline, 3 months, 6 months

    "Pediatric Quality of Life Inventory(Peds QL)" will be used as assessment tool for QOL among pediatric patients.

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Collaborators

  • Asan Medical Center
  • Chonbuk National University Hospital
  • Chonnam National University Hospital
  • Chungnam National University Hospital
  • Daegu Fatima Hospital
  • Ewha Womans University Mokdong Hospital
  • Gyeongsang National University Hospital
  • Hallym University Medical Center
  • Keimyung University Dongsan Medical Center
  • Kyunghee University Medical Center
  • National Cancer Center, Korea
  • National Clinical Research Coordination Center, Seoul, Korea
  • National Evidence-Based Healthcare Collaborating Agency
  • National Institute of Health, Korea
  • Seoul National University Bundang Hospital
  • Severance Hospital
  • Ulsan University Hospital

Registry information

Official study title

Change of Quality of Life, Treatment Decision and Utilization of Health Care Depending on the Use of Palliative Care in Adult and Pediatric Patients With Advanced Stage of Cancer: a Prospective Cohort Study

Important dates

Study start
2016
Primary completion
2019
Study completion
2020
First posted
Jul 19, 2017
Registry last updated
Mar 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.